New stock news | Real Biotech's IPO prospectus is invalid
Real Biotech Limited (referred to as Real Biotech) submitted its Hong Kong Stock Exchange prospectus on November 9, 2025, which expired after 6 months on May 9, 2026, with China International Capital Corporation serving as its exclusive sponsor at the time of submission.
The IPO prospectus of True BioTech Limited (referred to as True Bio) submitted on November 9, 2025 will expire after 6 months on May 9, 2026, with CICC being its exclusive sponsor at the time of submission.
The prospectus shows that True Bio is a bio-tech company founded in 2012, with a focus on innovative research and development in the treatment of viral infections, tumors, and cardiovascular and cerebrovascular diseases, as well as the development, manufacturing, and commercialization of innovative drugs.
Related Articles
HK Stock Market Move | Legend Holdings (03396) rose more than 4% in the morning with ATLATL releasing an AI-empowered virtual incubator in the AI era, jointly creating an AI+Biotech innovation empowerment system.
HK Stock Market Move | INNOGEN-B(02591) morning rise by over 43%Suba's Phase III weight loss data expected to be announced by the end of 2026.
HK Stock Market Move | Tensions between the US and Iran escalate, oil prices rise. China Eastern Airlines (00670) and Air China Limited (00753) both drop over 4%.
HK Stock Market Move | Legend Holdings (03396) rose more than 4% in the morning with ATLATL releasing an AI-empowered virtual incubator in the AI era, jointly creating an AI+Biotech innovation empowerment system.
HK Stock Market Move | INNOGEN-B(02591) morning rise by over 43%Suba's Phase III weight loss data expected to be announced by the end of 2026.
HK Stock Market Move | Tensions between the US and Iran escalate, oil prices rise. China Eastern Airlines (00670) and Air China Limited (00753) both drop over 4%.
